Can metoprolol be prescribed to a 25-year-old African male with hypertension?

Can Metoprolol Be Given to a 25-Year-Old African Male with Hypertension?

Metoprolol is not the optimal first-line choice for this patient; you should instead initiate treatment with a calcium channel blocker (CCB) or thiazide diuretic, either alone or in combination with a RAS blocker. 1

Guideline-Based Recommendations for African Patients

The most recent 2024 ESC guidelines explicitly state that in black patients, initial antihypertensive treatment should include a diuretic or a CCB, either in combination or with a RAS blocker 1. This recommendation is reinforced by the 2017 ACC/AHA guidelines, which note that thiazide diuretics or CCBs are more effective in lowering BP than RAS inhibitors or beta-blockers in black patients and are more effective in reducing cardiovascular events 1.

Why Beta-Blockers Are Not Preferred

• Beta-blockers like metoprolol are less effective at lowering blood pressure in African/black patients compared to diuretics or CCBs 1
• The ACC/AHA guidelines specifically state that beta-blockers offer no advantage over diuretics or CCBs in hypertensive patients without specific comorbidities like diabetes with nephropathy or heart failure 1
• Research from the PEAR2 study demonstrates that African Americans younger than 50 years responded similarly to both metoprolol and chlorthalidone, but this does not make metoprolol preferred when better options exist 2

Evidence Against Metoprolol in Young African Males

Several concerning findings emerge from the research:

• Metoprolol may eliminate the normal nighttime blood pressure dip in hypertensive black males, which is thought to protect against target organ damage 3
• In one study of 12 hypertensive black males, metoprolol had no significant effect on blood pressure despite causing significant heart rate reductions, and 58% of patients experienced clinically significant increases in daytime or nighttime blood pressure 3
• Metoprolol increases uric acid levels and risk of gout in African Americans, particularly those with chronic kidney disease 4

When Beta-Blockers Become Appropriate

Beta-blockers, including metoprolol, should be reserved for specific indications in this population:

• Compelling indications: Post-myocardial infarction, heart failure with reduced ejection fraction, or coronary heart disease 1
• As part of combination therapy: When initial therapy with CCB/diuretic/RAS blocker fails to achieve blood pressure control 1
• Resistant hypertension: The 2024 ESC guidelines recommend bisoprolol (not metoprolol specifically) as an option when first-line therapies fail 1

Recommended Initial Approach

For this 25-year-old African male with hypertension:

1. Start with a CCB (such as amlodipine) or thiazide diuretic (such as chlorthalidone) 1
2. Consider combination therapy from the start if blood pressure is significantly elevated (≥140/90 mmHg), as most patients, especially blacks, require ≥2 antihypertensive medications 1
3. A single-tablet combination including either a diuretic or CCB may be particularly effective in achieving BP control in black patients 1
4. Target blood pressure to <130/80 mmHg based on current guidelines 1

Important Caveats

• While metoprolol is FDA-approved and effective for hypertension in general populations 5, race-specific response differences are clinically significant and should guide initial therapy selection 1
• The pharmacokinetic profile shows that approximately 2% of most non-Caucasian populations are CYP2D6 poor metabolizers, which could lead to several-fold higher plasma concentrations and decreased cardioselectivity 5
• Do not withhold metoprolol if compelling indications exist (post-MI, heart failure, angina), but for uncomplicated hypertension in this demographic, choose guideline-concordant first-line agents 1